Gut regulation of bariatric surgery-induced bone loss
Gut regulation of bariatric surgery-induced bone loss
批准号:
10711698
负责人:
Ziru Li
金额:
$30.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-01 至 2028-08-31
关键词:
AblationAdipose tissueAdultAffectAnatomyAutomobile DrivingBiochemical PathwayBody CompositionBody WeightBody Weight decreasedBone DensityBone MarrowBone Marrow CellsBone remodelingBreedingCardiovascular DiseasesCell SeparationCellsCellular Metabolic ProcessCenters of Research ExcellenceClinical ManagementConsumptionDataDietary CalciumDiphtheria ToxinDoctor of PhilosophyEndocrineEndocrine GlandsEnergy MetabolismExcisionExerciseFRAP1 geneFatty LiverFoodFractureGastrectomyGastric GlandsGastrinsGoalsHematopoiesisHematopoieticHematopoietic stem cellsHistamineHistologicHistopathologyHomeostasisHormonesHumanIn VitroInflammatoryLeadLipidsMalignant NeoplasmsMalnutritionMarrowMechanicsMediatingMentorsMesenchymalMicroscopyModelingMolecular AnalysisMonitorMorbid ObesityMusMyelogenousMyeloid CellsNon-Insulin-Dependent Diabetes MellitusObesityOperative Surgical ProceduresOsteogenesisPatientsPhasePhenotypePhysiologyPopulationPreventiveProceduresProteinsProteomicsRegulationReporterResearchResearch PersonnelRiskRodentSecondary toServicesSignal TransductionSiteSkeletonSomatostatinSourceStomachTestingTherapeuticTissuesVitamin DWeight-Bearing statebariatric surgerybonebone cellbone lossbone massbone metabolismdesignfracture riskgastric secretion substanceghrelinglucose metabolismhigh riskimprovedin vivo Modelinsightlipid biosynthesislipid metabolismlipidomicsmicrobiotaneglectneuroregulationnew therapeutic targetnovelobese patientsosteoclastogenesisosteogenicpandemic diseasepreventprotective effectprotein profilingside effectskeletaltranscriptomics
中文摘要
肠道调节减肥手术引起的骨丢失(Z。Li,项目负责人)
减肥手术相关的骨骼并发症包括骨折的两倍风险,
自20世纪90年代初以来一直被观察到。最常见的减肥手术是垂直袖状胃切除术
(VSG),这导致6-24个月后中轴骨约3-7%的骨丢失。当前临床管理
包括骨矿物质密度评估,摄入充足的膳食钙、维生素D和蛋白质,
和负重锻炼。这些对策最大限度地减少,但不能完全防止继发性骨丢失
减肥手术更好地了解与减肥手术相关的骨丢失机制,
适当设计和评估预防和治疗策略是必要的。肠道激素的变化
和微生物群是驱动骨丢失的潜在机制,但主要手术部位(
胃)在很大程度上被忽视了。我们认为胃激素有助于减肥手术-
引起骨骼并发症。在关键的初步数据中,我们发现了胃X/A样细胞(人类的P/D1细胞),
一个独特的内分泌细胞群,有助于调节全球脂质代谢,骨髓肥胖
和骨形成,这表明胃骨轴。本提案的目的是:1)确定
胃X/A样细胞源性分泌因子对VSG诱导的骨丢失的影响; 2)鉴定和
表征来自调节骨髓的X/A样细胞的胃激素(除生长激素释放肽外)
细胞和骨骼稳态。对于第一个目标,我们将利用白喉毒素模型来消耗X/A样细胞
在成年小鼠胃中,并分析骨参数以确定X/A样细胞在
骨稳态此外,VSG后X/A样细胞源性ghrelin浓度降低;
因此,我们将测试ghrelin对VSG诱导的骨并发症的保护作用。第二
目的:我们将确定X/A样细胞来源的分泌蛋白对脂肪形成、骨重建和骨形成的影响。
造血此外,将进行无偏倚的转录组学和蛋白质组学筛选以确定
X/A样细胞分泌组。本项目将得到生理学核心的支持,用于分析小鼠身体
成分、活动和能量消耗。组织学和显微镜核心将提供服务
通过组织学和免疫染色分析表征组织(肠和骨)表型。的
Proteomics和Lipidomics Core将对胃X/A样细胞分泌组进行蛋白质分析。的
所提出的策略将严格检验胃X/A样细胞衍生的分泌因子
导致与VSG相关的骨骼并发症。确定该细胞群在以下方面的重要性:
骨代谢将提供新的治疗靶点来控制减肥手术引起的骨丢失。这
项目由新的初级研究员李子如博士领导,他将得到杰出专家导师的支持,
减肥手术(Randy塞利博士)和骨稳态和重塑(Clifford罗森医学博士)。
英文摘要
Gut regulation of bariatric surgery-induced bone loss (Z. Li, Project Lead)
Bariatric surgery-associated skeletal complications include a two-fold risk in bone fracture, a side effect that
has been observed since the early 1990s. The most common bariatric surgery is vertical sleeve gastrectomy
(VSG), which leads to ~3-7% bone loss at the axial skeleton after 6-24 months. Current clinical management
includes bone mineral density assessments, consumption of adequate dietary calcium, vitamin D and protein,
and weight-bearing exercise. These countermeasures minimize, but do not fully prevent bone loss secondary
to bariatric surgery. A better mechanistic understanding of bone loss associated with bariatric surgery is
necessary to properly design and evaluate preventive and therapeutic strategies. Changes in gut hormones
and microbiota are potential mechanisms driving bone loss, but the contribution of the major surgical site (the
stomach) has been largely neglected. We propose that gastric hormones contribute to bariatric surgery-
induced skeletal complications. In key preliminary data, we found gastric X/A-like cells (P/D1 cells in humans),
a unique endocrine cell population, contribute to the regulation of global lipid metabolism, marrow adiposity
and bone formation, suggesting a stomach-bone axis. The aims of this proposal are: 1) to determine the
effects of gastric X/A-like cell-derived secretory factors on VSG-induced bone loss; and 2) to identify and
characterize gastric hormones (in additional to ghrelin) derived from X/A-like cells that regulate bone marrow
cells and skeletal homeostasis. For the first aim, we will utilize a diphtheria toxin model to deplete X/A-like cells
in the adult mouse stomach, and analyze bone parameters to determine the importance of X/A-like cells in
bone homeostasis. In addition, X/A-like cell derived ghrelin concentrations are decreased following VSG;
therefore, we will test the protective effects of ghrelin on VSG-induced bone complications. For the second
aim, we will determine the effects of X/A-like cell-derived secretome on adipogenesis, bone remodeling and
hematopoiesis. Furthermore, unbiased transcriptomic and proteomic screens will be performed to define the
secretome of X/A-like cells. This project will be supported by the Physiology Core for analyses of mouse body
composition, activity, and energy expenditure. The Histopathology and Microscopy Core will provide services
to characterize the tissue (gut and bone) phenotypes via histological and immunostaining analyses. The
Proteomics and Lipidomics Core will perform protein profiling of the gastric X/A-like cell secretome. The
proposed strategy will rigorously test the hypothesis that gastric X/A-like cell-derived secretory factors
contribute to VSG-associated skeletal complications. Determination of the importance of this cell population in
bone metabolism will provide new therapeutic targets for managing bariatric surgery-induced bone loss. This
project is led by a new junior investigator, Dr. Ziru Li, who will be supported by outstanding expert mentors in
bariatric surgery (Randy Seeley PhD), and bone homeostasis and remodeling (Clifford Rosen MD).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gut regulation of bariatric surgery-induced bone loss
-
批准号:10665189
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2022
-
负责人:Ziru Li
-
依托单位:
海外基金